Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]
- DOI
- 10.1016/j.intimp.2026.117587
- Published
- 2026-11
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117587,
title = {Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]},
author = {Lvwen Zhang and Zhenyu Song and Xike Mao and Yuehan Yang and Bingbing Hou and Yang Chen and Zongyao Hao},
year = {2026},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117587},
url = {https://doi.org/10.1016/j.intimp.2026.117587}
}RIS
TY - JOUR TI - Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864] AU - Lvwen Zhang AU - Zhenyu Song AU - Xike Mao AU - Yuehan Yang AU - Bingbing Hou AU - Yang Chen AU - Zongyao Hao PY - 2026 JO - International Immunopharmacology DO - 10.1016/j.intimp.2026.117587 UR - https://doi.org/10.1016/j.intimp.2026.117587 ER -
APA
Zhang, L., Song, Z., Mao, X., Yang, Y., Hou, B., Chen, Y., & Hao, Z. (2026). Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117587
Source records
- crossref · retrieved 2026-11-09T07:18:00.827Z